Penicillin-nonsusceptible Pneumococcus

International Journal of Antimicrobial Agents

Volumn 14, Issue 2, 2000, Pages 123-127

  Leggiadro, Robert J ^a,b  

^a Sisters of Charity Medical Center   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Beta lactam; Meningitis; Penicillin binding proteins

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFEPIME; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME AXETIL; CEPHALOSPORIN; CHLORAMPHENICOL; DEXAMETHASONE; ERYTHROMYCIN; IMIPENEM; LEVOFLOXACIN; LORACARBEF; MEROPENEM; PENICILLIN BINDING PROTEIN; PENICILLIN G; PNEUMOCOCCUS VACCINE; RIFAMPICIN; SPARFLOXACIN; SULFAFURAZOLE; VANCOMYCIN;

AGE; AGED; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; BACTERIAL MENINGITIS; CAUCASIAN; CHILD; DAY CARE; DISEASE TRANSMISSION; HOSPITALIZATION; HUMAN; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; MUTATION; NURSING HOME; OTITIS MEDIA; PNEUMONIA; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEPSIS; SEROTYPE; SOCIOECONOMICS; STREPTOCOCCUS PNEUMONIAE;

EID: 0034057819     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(99)00171-5     Document Type: Article

References (39)

1. Butler J.C., Hofman J., Cetron M.S., Elliott J.A., Facklam R.R., Breiman R.F. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System. J. Infect. Dis. 174:1996;986-993.
2. Bradley J.S., Kaplan S.L., Klugman K.P., Leggiadro R.J. Consensus: management of infections in children caused by Streptococcus pneumoniae with decreased susceptibility to penicillin. Pediatr. Infect. Dis. J. 14:1995;1037-1041.
3. Sloas M.M., Barrett F.F., Chesney P.J. et al. Cephalosporin treatment failure in penicillin- and cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr. Infect. Dis. J. 11:1992;662-666.
4. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Villanova, PA: National Committee for Clinical Laboratory Standards 14 (16), 1994.
5. Coffey T.J., Dowson C.G., Daniels M. et al. Genetics and molecular biology of beta-lactam-resistant pneumococci. Microb. Drug. Resist. 1:1995;29-34.
6. Coffey T.J., Daniels M., McDougal L.K. et al. Genetic analysis of clinical isolates of Streptococcus pneumoniae with high-level resistance to expanded-spectrum cephalosporins. Antimicrob. Agents. Chemother. 39:1995;1306-1313.
7. Applebaum P.C. Antimicrobial resistance in Streptococcus pneumoniae. An overview. Clin. Infect. Dis. 15:1992;77-83.
8. Nesin M., Ramirez M., Tomasz A. Capsular transformation of a multidrug-resistant Streptococcus pneumoniae in vivo. J. Infect. Dis. 177:1998;707-713.
9. Arnold K.E., Leggiadro R.J., Breiman R.F. et al. Risk factors for carriage of drug-resistant Streptococcus pneumoniae among children in Memphis, Tennessee. J. Pediatr. 128:1996;757-764.
10. Ilyas M., Roy S., Abbasi S. et al. Serious infections due to penicillin-resistant Streptococcus pneumoniae in two children with nephrotic syndrome. Pediatr. Nephrol. 10:1996;639-641.
11. Reichler M.R., Allphin A.A., Brieman R.F. et al. The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio. J. Infect. Dis. 166:1992;1346-1353.
12. Hofman J., Cetron M.S., Farley M.M. et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. New. Engl. J. Med. 333:1995;481-486.
13. Butler J.C., Cetron M.S. Pneumococcal drug resistance: the new special enemy of old age? Clin. Infect. Dis. 28:1999;730-735.
14. Centers for Disease Control and Prevention: Defining the public health impact of drug-resistant Streptococcus pneumoniae: report of a working group. MMWR 45 (No. RR-1), 1996.
15. Leggiadro R.J., Barrett F.F., Chesney P.J., Davis Y., Tenover F.C. Invasive pneumococci with high-level penicillin resistance at a children's hospital. Pediatr. Infect. Dis. J. 13:1994;320-322.
16. Paris M.M., Ramilo O., McCracken G.H. Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae. Antimicrob. Agents Chemother. 39:1995;2171-2175.
17. Pallares R., Linares J., Vadillo M. et al. Resistance to penicillin and cephalosporin and mortality from pneumococcal pneumonia in Barcelona, Spain. New Engl. J. Med. 333:1995;474-480.
18. Leggiadro R.J., Davis Y., Tenover F.C. Outpatient drug-resistant pneumococcal bacteremia. Pediatr. Infect. Dis. J. 13:1994;1144-1146.
19. Abbasi S., Orlicek S.L., Almohsen I., Luedtke G., English B.K. Septic arthritis and osteomyelitis caused by penicillin- and cephalosporin-resistant Streptococcus pneumoniae in a children's hospital. Pediatr. Infect. Dis. J. 15:1996;78-83.
20. Schuchat A., Robinson K., Wenger J.D. et al. Bacterial meningitis in the United States. New Engl. J. Med. 337:1995;970-976.
21. Viladrich P.F., Gudiol F., Linares J., Rufi G., Ariza J., Pallares R. Characteristics and antibiotic therapy of adult meningitis due to penicillin-resistant pneumococci. Am. J. Med. 84:1988;839-846.
22. Friedland I.R., McCracken G.H. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. New Engl. J. Med. 331:1994;377-382.
23. Friedland I.R., Klugman K.P. Failure of chloramphenicol therapy in penicillin-resistant pneumococcal meningitis. Lancet. 339:1992;405-408.
24. Friedland I.R., Paris M., Ehrett S. et al. Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob. Agents. Chemother. 37:1993;1630-1636.
25. Leggiadro R.J. Penicillin- and cephalosporin-resistant Streptococcus pneumoniae: an emerging microbial threat. Pediatrics. 93:1994;500-503.
26. American Academy of Pediatrics Committee on Infectious Diseases: Therapy for children with invasive pneumococcal infections. Pediatrics 1997;99:289-99.
27. Bartlett J.G., Brieman R.F., Mandell L.A., File T.M. Community-acquired pneumonia in adults: guidelines for management. Clin. Infect. Dis. 26:1998;811-838.
28. Chesney P.J., Wilimas J.A., Presbury G. et al. Penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae causing sepsis and meningitis in children with sickle cell disease. J. Pediatr. 127:1995;526-532.
29. Frankel R.E., Virata M., Hardalo C. et al. Invasive pneumococcal disease: clinical features, serotypes, and antimicrobial resistance patterns in cases involving patients with and without human immunodeficiency virus infection. Clin. Infect. Dis. 23:1996;577-584.
30. Mao C., Harpen M., McIntosh K. et al. Invasive pneumococcal infections in human immunodeficiency virus-infected children. J. Infect. Dis. 173:1996;870-876.
31. Dagan R., Abramson O., Leibovitz E. et al. Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin. Pediatr. Infect. Dis. J. 15:1996;980-985.
32. Dowell S.F., Butler J.C., Giebink G.S. et al. Acute otitis media: management and surveillance in an era of pneumococcal resistance-a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr. Infect. Dis. J. 18:1999;1-9.
33. Kristinsson KG, Hjalmarsdottir MA, Gndnason TH. Epidemiology of penicillin-resistant pneumococci in Iceland-hope for the future? (Abstract C9). In Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, 1995.
34. Dowell S.F., Marcy S.M., Phillips W.R., Gerber M.A., Schwartz B. Otitis media-principles of judicious use of antimicrobial agents. Pediatrics. 101:1998;165-171.
35. Centers for Disease Control and Prevention: Prevention of pneumococcal disease. MMWR 1997; 46 (RR-8): 1-24.
36. Black S, Shinefield H, Ray P, et al. Efficacy of heptavalent conjugate pneumococcal vaccine (Wyeth Lederle) in 37 000 infants and children: results of the Northern California Kaiser Permanente Efficacy Trial. LB-9. In: Program and abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, DC, 1989.
37. Carter R, Sorensen G, Kornblum J, Kiehlbauch J, Leggiadro R, Layton M. Outbreak of multidrug-resistant Streptococcus pneumoniae (MDRSP) at a long-term care facility for persons with AIDS. In: Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, September 28-October 1, 1997. Washington, DC: American Society for Microbiology, 1997: 55 abstract.
38. Nuorti J.P., Butler J.C., Crutcher J.M. et al. An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents. New Engl. J. Med. 338:1998;1861-1868.
39. Rauch A., O'Ryan M., Van R., Pickering L.K. Invasive disease due to multiply resistant Streptococcus pneumoniae in a Houston, Texas, day-care center. AJDC. 144:1990;923-927.